Natriuretic peptide as an adjunctive diagnostic test in the acute phase of kawasaki disease

Pediatric Cardiology

Volumn 30, Issue 6, 2009, Pages 810-817

  Dahdah, Nagib ^a   Siles, Ana ^a   Fournier, Anne ^a   Cousineau, Jocelyne ^a   Delvin, Edgard ^a   Saint Cyr, Claire ^a   Spiegelblatt, Linda ^b   Bonny, Yvette ^b   Vartian, Michèle ^c   Montigny, Martine ^c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c Hopital de la Cite de la Sante   (Canada)

Author keywords

B type natriuretic peptide (BNP); Carditis; Myocardial dysfunction; N terminal moiety of BNP (NT proBNP)

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN;

ACUTE DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 68449101093     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-009-9441-2     Document Type: Article

References (48)

1. S Albers TS Mir M Haddad S Läer 2006 N-terminal pro brain natriuretic peptide: evaluation of pediatric reference values including method comparison and interlaboratory variability Clin Chem Lab Med 44 80 85
2. T Anderson RA Meyer S Kaplan 1985 Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease Am Heart J 110 107 115
3. M Ayusawa H Kanamaru K Karasawa N Noto N Sumitomo H Yamaguchi H Izumi T Okada K Harada 2002 Estimation of "selective" intravenous gamma globulin treatment indicated by Harada score Pediatr Res 53 1 181 (abstr)
4. M Ayusawa T Sonobe S Uemura S Ogawa Y Nakamura N Kiyosawa M Ishii K Harada 2005 Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) Pediatr Int 47 232 234
5. ED Belay RA Maddox RC Holman AT Curns K Ballah LB Schonberger 2006 Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003 Pediatr Infect Dis J 25 245 249
6. JC Burns WH Mason MP Glode ST Shulman ME Melish C Meissner J Bastian AS Beiser HM Meyerson JW Newburger 1991 Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group J Pediatr 118 5 680 686
7. PA Checchia J Borensztajn ST Shulman 2001 Circulating cardiac troponin I levels in Kawasaki disease Pediatr Cardiol 22 102 106
8. LC Costello-Boerrigter G Boerrigter MM Redfield RJ Rodeheffer LH Urban DW Mahoney SJ Jacobsen DM Heublein JC Burnett 2006 Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction J Am Coll Cardiol 47 345 353
9. NS Dahdah E Jaeggi A Fournier 2002 Electrocardiographic depolarization and repolarization: long-term after Kawasaki disease Pediatr Cardiol 23 5 513 517
10. N Dahdah R Ibrahim L Cannon 2007 First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter Pediatr Cardiol 28 5 389 393
11. JA de Lemos DK [tmp] McGuire MH Drazner 2003 B-type natriuretic peptide in cardiovascular disease Lancet 362 9380 316 322
12. H Fujiwara Y Hamashima 1978 Pathology of the heart in Kawasaki disease Pediatrics 61 1 100 107
13. FD Hobbs RC Davis AK Roalfe R Hare MK Davies JE Kenkre 2004 Reliability of N-terminal proBNP assay in diagnosis of left ventricular dysfunction within representative and high risk population Heart 90 866 870
14. VEA Honkanen BW [tmp] McCrindle RM Laxer BM Feldman R Schneider ED Silverman 2003 Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease Pediatr Cardiol 24 122 126
15. M Ishii T Ueno H Ikeda M Iemura T Sugimura J Furui Y Sugahara H Muta T Akagi Y Nomura T Homma H Yokoi M Nobuyoshi T Matsuishi H Kato 2000 Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study Circulation 105 3004 3010
16. C Kao K Hsieh Y Wang CW Chen SQ Liao SJ Wang SH Yeh 1992 Tc-99 m HMPAO labeled WBC scan for the detection of myocarditis in different phases of Kawasaki disease Clin Nucl Med 17 185 190
17. CH Kao KS Hsieh CW Chen YL Wang SJ Wang SH Yeh 1995 Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globulin treatment in Kawasaki disease Clin Nucl Med 20 813 816
18. RE Kavey V Allada SR Daniels LL Hayman BW [tmp] McCrindle JW Newburger RS Parekh J Steinburger 2006 Cardiovascular risk reduction in high-risk pediatric patients. A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research Circulation 114 2710 2738
19. T Kawamura M Wago 2002 Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease Cardiol Young 12 153 158
20. T Kawamura M Wago H Kawagushi M Tahara M Yuge 2000 Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease Pediatr Int 42 241 248
21. T Kawasaki 1967 Acute febrile mucocutaneous syndrome Jpn J Allergy 16 178 222
22. M Kim K Kim 1998 Changes in cardiac troponin I in Kawasaki disease before and after treatment with intravenous gammaglobulin Jpn Circ J 62 479 482
23. M Kim K Kim 1999 Elevation of cardiac troponin I in the acute stage of Kawasaki disease Pediatr Cardiol 20 184 188
24. S Kurotobi N Kawakami K Shimizu H Aoki S Nasuno H Takahashi S Kogaki K Ozono 2005 Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease Pediatr Cardiol 26 425 430
25. AM Liu M Ghazizadeh Z Onouchi G Asano 1999 Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease Microvasc Res 58 10 27
26. BW [tmp] McCrindle JS Li LL Minich SD Colan AM Atz M Takahashi VL Vetter WM Gersony PD Mitchell JW Newburger for the Pediatric Heart Network Investigators 2007 Coronary artery involvement in children with Kawasaki disease risk factors from analysis of serial normalized measurements Circulation 116 174 179
27. AM Moran JW Newburger SP Sanders IA Parness PJ Spevak JC Burns SD Colan 2000 Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin Am Heart J 139 217 223
28. N Moreno A Méndez-Echevarría J de Inocencio F del Castillo F Baquero-Artiago MJ García-Miguel MI de José J Aracil 2008 Coronary involvement in infants with Kawasaki disease treated with intravenous G-globulin Pediatr Cardiol 29 1 31 35
29. T Mueller A Gegenhuber W Poelz M Haltmayer 2003 Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease Clin Chem 49 976 979
30. Y Nakamura H Yanagawa K Harada H Kato T Kawasaki 2002 Mortality among persons with a history of Kawasaki disease in Japan: the fifth look Arch Pediatr Adolesc Med 156 2 162 165
31. Y Nakamura M Yashiro R Uehara M Watanabe M Tajimi I Oki T Ojima T Sonobe H Yanagawa 2004 Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease Pediatr Int 46 33 38
32. H Nakano A Saito K Ueda K Nojima 1986 Clinical and characteristics of myocardial infarction following Kawasaki disease: report of 11 cases J Pediatr 108 198 203
33. K Nakao Y Ogawa S-I Suga H Imura 1992 Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors J Hypertens 10 1111 1114
34. JW Newburger S Sanders JC Burns IA Parness AS Beiser SD Colan 1989 Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gammaglobulin Circulation 79 1237 1246
35. JW Newburger M Takahashi MA Gerber MH Gewitz LY Tani JC Burns ST Shulman AF Bolger P Ferrieri RS Baltimore WR Wilson LM Baddour ME Levison TJ Pallasch DA Falace KA Taubert 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2747 2771 (Pubitemid 39453026)
36. A Nir B Bar-Oz Z Perles R Brooks A Korach A Rein 2004 N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence: elevated levels at birth and in heart diseases Acta Paediatr 93 603 607
37. A Nir A Lindinger M Rauh B Bar-Oz S Laer L Schwanchtgen A Koch J Falkenberg TS Mir 2009 NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies Pediatr Cardiol 30 3 8
38. T Sonobe N Kiyosawa K Tsuchia S Aso Y Imada Y Imai M Yashiro Y Nakamura H Yanagawa 2007 Prevalence of coronary artery abnormality in incomplete Kawasaki disease Pediatr Int 49 421 426
39. M Takahashi 1989 Myocarditis in Kawasaki syndrome: a minor villain? Circulation 79 1398 1400
40. M Takeuchi T Matsushita S Kurotobi T Sano S Kogaki K Ozono 2006 Application of signal-averaged electrocardiogram to myocardial damage in the late stage of Kawasaki disease Circ J 70 11 1443 1445
41. D Takeuchi T Saji S Takatsuki M Fujiwara 2007 Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease Circ J 71 357 362
42. CF Tseng YC FU LS Fu H Betau CS Chi 2001 Clinical spectrum of Kawasaki disease in infants Zhonghua Yi Xue Za Zhi (Taipei) 64 168 173
43. E Tsuda S Kitamura K Kimura J Kobayashi S Miyazaki S Echigo T Yagihara 2002 Long-term patency of internal thoracic artery graft of coronary artery stensosis due to Kawasaki disease: comparison of early with recent results in small children Am Heart J 153 6 995 1000
44. E Tsuda T Kamiya Y Ono K Kimura K Kurosaki S Echigo 2005 Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease Pediatr Cardiol 26 73 79
45. M Vanderheyden J Bartunek M Goethals 2004 Brain and other natriuretic peptides: molecular aspects Eur J Heart Fail 6 3 261 268
46. WH Wilson Tang 2007 B-type natriuretic peptide: a critical review CHF 13 48 52
47. S Yonesaka T Takahashi T Matubara T Nakada H Furukawa K Tomimoto H Oura 1991 Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequellae and regional wall motion abnormalities of the left ventricle Jpn Circ C 56 352 358
48. C Yutani S Go T Kamiya O Hirose H Misawa H Maeda T Kozuka S Onishi 1981 Cardiac biopsy of Kawasaki disease Arch Pathol Lab Med 105 470 473